+ Follow DR. GERRY TAN Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1312532
[Title] => Managing diabetes
[Summary] => The rapid growth of diabetes cases in the country shouldn't come as a surprise for a carbohydrate-loading nation.
[DatePublished] => 2014-04-14 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1489320
[AuthorName] => Maria Eleanor E. Valeros
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[1] => Array
(
[ArticleID] => 378942
[Title] => Landmark diabetes trial seen to control blood sugar better
[Summary] =>
You are what you eat! Whatever you feed yourself will likely speak highly or poorly of you. Like words that come out of your mouth which might be taken one day against you, what you had indulged in gastronomically during the holidays - oh, all of those tempting sweets and starchies and lots of other sinful goodies - could be detrimental to the activities of the endocrine system.
[DatePublished] => 2007-01-08 00:00:00
[ColumnID] => 133560
[Focus] => 0
[AuthorID] => 1489320
[AuthorName] => Maria Eleanor E. Valeros
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[2] => Array
(
[ArticleID] => 375197
[Title] => Drug found to delay type 2 diabetes
[Summary] =>
Type 2 diabetes patients can now look forward to the potential prevention of complications of said disease after an international study found out that rosiglitazone maleate has successfully reduced the risk of monotherapy failure in people who have the disease.
Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with rosiglitazone maleate reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin, and 63 percent compared to glyburide at five years.
[DatePublished] => 2006-12-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Cebu News
[SectionUrl] => cebu-news
[URL] =>
)
)
)
DR. GERRY TAN
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1312532
[Title] => Managing diabetes
[Summary] => The rapid growth of diabetes cases in the country shouldn't come as a surprise for a carbohydrate-loading nation.
[DatePublished] => 2014-04-14 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1489320
[AuthorName] => Maria Eleanor E. Valeros
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[1] => Array
(
[ArticleID] => 378942
[Title] => Landmark diabetes trial seen to control blood sugar better
[Summary] =>
You are what you eat! Whatever you feed yourself will likely speak highly or poorly of you. Like words that come out of your mouth which might be taken one day against you, what you had indulged in gastronomically during the holidays - oh, all of those tempting sweets and starchies and lots of other sinful goodies - could be detrimental to the activities of the endocrine system.
[DatePublished] => 2007-01-08 00:00:00
[ColumnID] => 133560
[Focus] => 0
[AuthorID] => 1489320
[AuthorName] => Maria Eleanor E. Valeros
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[2] => Array
(
[ArticleID] => 375197
[Title] => Drug found to delay type 2 diabetes
[Summary] =>
Type 2 diabetes patients can now look forward to the potential prevention of complications of said disease after an international study found out that rosiglitazone maleate has successfully reduced the risk of monotherapy failure in people who have the disease.
Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with rosiglitazone maleate reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin, and 63 percent compared to glyburide at five years.
[DatePublished] => 2006-12-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Cebu News
[SectionUrl] => cebu-news
[URL] =>
)
)
)
abtest
December 15, 2006 - 12:00am
